Forbes JM - Search Results

1

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial.

Baye E, de Courten MP, Walker K, Ranasinha S, Earnest A, Forbes JM, de Courten B. Baye E, et al. Among authors: forbes jm. Sci Rep. 2017 Jun 23;7(1):4123. doi: 10.1038/s41598-017-04214-6. Sci Rep. 2017. PMID: 28646140 Free PMC article. Clinical Trial.

2

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.

Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM. Candido R, et al. Among authors: forbes jm. Circ Res. 2003 Apr 18;92(7):785-92. doi: 10.1161/01.RES.0000065620.39919.20. Epub 2003 Mar 6. Circ Res. 2003. PMID: 12623881

3

Role of advanced glycation end products in diabetic nephropathy.

Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Forbes JM, et al. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S254-8. doi: 10.1097/01.asn.0000077413.41276.17. J Am Soc Nephrol. 2003. PMID: 12874442 Review.

4

Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?

Thomas MC, Forbes JM, MacIsaac R, Jerums G, Cooper ME. Thomas MC, et al. Among authors: forbes jm. Ann N Y Acad Sci. 2005 Jun;1043:644-54. doi: 10.1196/annals.1333.073. Ann N Y Acad Sci. 2005. PMID: 16037288 Review.

5

Interactions between renin angiotensin system and advanced glycation in the kidney.

Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, Coughlan MT, Jandeleit-Dahm K, Cooper ME, Forbes JM. Thomas MC, et al. Among authors: forbes jm. J Am Soc Nephrol. 2005 Oct;16(10):2976-84. doi: 10.1681/ASN.2005010013. Epub 2005 Aug 17. J Am Soc Nephrol. 2005. PMID: 16107577

6

Advanced glycation end products and diabetic nephropathy.

Thomas MC, Forbes JM, Cooper ME. Thomas MC, et al. Among authors: forbes jm. Am J Ther. 2005 Nov-Dec;12(6):562-72. doi: 10.1097/01.mjt.0000178769.52610.69. Am J Ther. 2005. PMID: 16280650 Review.

7

Oxidative stress and advanced glycation in diabetic nephropathy.

Coughlan MT, Mibus AL, Forbes JM. Coughlan MT, et al. Among authors: forbes jm. Ann N Y Acad Sci. 2008 Apr;1126:190-3. doi: 10.1196/annals.1433.018. Ann N Y Acad Sci. 2008. PMID: 18448815

8

Advanced glycation: implications in tissue damage and disease.

Gasser A, Forbes JM. Gasser A, et al. Among authors: forbes jm. Protein Pept Lett. 2008;15(4):385-91. doi: 10.2174/092986608784246515. Protein Pept Lett. 2008. PMID: 18473952

9

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.

Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA. Soro-Paavonen A, et al. Among authors: forbes jm. Diabetes. 2008 Sep;57(9):2461-9. doi: 10.2337/db07-1808. Epub 2008 May 28. Diabetes. 2008. PMID: 18511846 Free PMC article.

10

c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals.

Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM, de Courten B. Sourris KC, et al. Among authors: forbes jm. Diabetes. 2009 Jun;58(6):1259-65. doi: 10.2337/db08-1725. Epub 2009 Mar 3. Diabetes. 2009. PMID: 19258436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page